Pentadeca Arginate Reference
Educational, not medical advice reference for Pentadeca Arginate: Recovery; regulatory status, evidence posture, source review, and schedule not…
Plain English
- What it is
- Pentadeca Arginate, usually shortened to PDA, is a lab-made peptide that shows up in the peptide and research-chemical community. It is not an FDA-approved medicine. People treat it as a more stable cousin of an older peptide called BPC-157.
- What people use it for
- In the community it gets tried in hopes of faster healing and recovery, such as repair of muscles, tendons, the gut, and other tissues. Those hopes come from BPC-157 stories and animal research, not from any study of PDA itself.
- What the science shows
- There are no published peer-reviewed studies and no registered clinical trials on Pentadeca Arginate itself. The healing claims are borrowed from BPC-157, and even that research is almost entirely in animals, not people. BPC-157 has not been approved by the FDA because there is not enough human evidence.
- The catch
- Because PDA has never been tested on its own, its real benefits and safety in people are simply not known. The peptide it copies, BPC-157, is not FDA-approved and is only now under federal review for whether it may even be used in compounding, with an advisory committee set to discuss it on July 23, 2026.
Reference summary
No independent PubMed-indexed human clinical or peer-reviewed preclinical data for Pentadeca Arginate specifically are published at the time of review. Marketing materials extrapolate from BPC-157 research, but the two are not the same molecule.
Regulatory and posture
- Categories
- Recovery
- Aliases
- PDA, Pentadecapeptide arginate, Arginate-salt BPC-157 analog
- Evidence posture
- preclinical - No independent peer-reviewed human or preclinical data published for Pentadeca Arginate itself. Claims extrapolate from BPC-157 research.
- Regulatory status
- No FDA-approved Pentadeca Arginate drug label. PDA is a newer community compound marketed as a salt-stabilized analog of BPC-157. It lacks independent peer-reviewed human clinical evidence.
- Content review status
- research reference
Selected public sources
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.
For research and educational purposes only. Not medical advice.